Home

LATEST ARTICLES
Authors: Hart RG, Sharma M, Mundl et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 2018; 378:2191-201. Reviewed by:  Kyle Hobbs, MD, Assistant Professor, ...
Authors: Lahiri, S., Nezhad, M., Schlick, K.H., et al. Paradoxical cerebrovascular hemodynamic changes with nicardipine. J Neurosurg 128: 1015-1019, 2018. Reviewed by: Aimee Aysenne MD, MPH, Assistant ...
PRODUCT OF THE MONTH
Brain Death Toolkit

The NCS Annual Meeting is uniquely designed for physicians, nurses, pharmacists and other healthcare specialists, including residents/fellows, who care for neurocritical care patients


NCS would like to thank the following companies who have supported NCS year-round:

Abbott
Arbor Pharmaceuticals
Biogen
Chiesi
NeurOptics
Portola Pharmaceuticals
UCB
ZOLL